Suppr
超能文献

The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants.

作者信息

Wangge Grace, Roes Kit C B, de Boer Anthonius, Hoes Arno W, Knol Mirjam J

机构信息

Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

出版信息

CMAJ. 2013 Feb 19;185(3):222-7. doi: 10.1503/cmaj.120142. Epub 2012 Aug 20.

DOI:10.1503/cmaj.120142

PMID:22908144

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3576440/

Abstract

摘要

相似文献

The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants.

CMAJ. 2013 Feb 19;185(3):222-7. doi: 10.1503/cmaj.120142. Epub 2012 Aug 20.

Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.

Semin Vasc Surg. 2011 Sep;24(3):157-61. doi: 10.1053/j.semvascsurg.2011.11.003.

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.

J Thromb Haemost. 2018 Sep;16(9):1891-1894. doi: 10.1111/jth.14219. Epub 2018 Jul 19.

Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.

Cochrane Database Syst Rev. 2020 Oct 10;10(10):CD013399. doi: 10.1002/14651858.CD013399.pub2.

Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.

Ann Intern Med. 2012 Dec 4;157(11):796-807. doi: 10.7326/0003-4819-157-10-201211200-00532.

Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?

Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177.

A Review of the Efficacy and Safety Profiles of the Novel Oral Anticoagulants in the Treatment and Prevention of Venous Thromboembolism.

Clin Ther. 2018 Dec;40(12):2140-2167. doi: 10.1016/j.clinthera.2018.10.009. Epub 2018 Nov 5.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Cochrane Database Syst Rev. 2014 Aug 29(8):CD008500. doi: 10.1002/14651858.CD008500.pub3.

A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies.

Open Med. 2014 May 6;8(2):e67-72. eCollection 2014.

Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.

BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785.

引用本文的文献

Intracorporeal lithotripsy of salivary stones: in vitro comparison of different methods.

Eur Arch Otorhinolaryngol. 2025 Mar 7. doi: 10.1007/s00405-025-09268-1.

Comparison of BMI changes in Japanese adults receiving face-to-face versus online counseling for specific health guidance: a noninferiority prospective observational study.

J Occup Health. 2024 Jan 4;66(1). doi: 10.1093/joccuh/uiae026.

Protocol for a Randomized Control Trial for Tungiasis Treatment in Homa Bay County, Kenya: Dimeticone versus Sodium Carbonate.

Methods Protoc. 2023 Jan 23;6(1):12. doi: 10.3390/mps6010012.

Non-inferiority Testing for Risk Ratio, Odds Ratio and Number Needed to Treat in Three-arm Trial.

Comput Stat Data Anal. 2019 Apr;132:70-83. doi: 10.1016/j.csda.2018.08.018. Epub 2018 Sep 15.

A note on the determination of non-inferiority margins with application in oncology clinical trials.

Contemp Clin Trials Commun. 2019 Sep 23;16:100454. doi: 10.1016/j.conctc.2019.100454. eCollection 2019 Dec.

Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.

Stat Biopharm Res. 2019;11(1):34-43. doi: 10.1080/19466315.2018.1554504. Epub 2019 Apr 22.

A Local Sensitivity Analysis of the Trial of Continuous or Interrupted Chest Compressions during Cardiopulmonary Resuscitation: Is a Local Protocol Change Required?

Cureus. 2018 Sep 29;10(9):e3386. doi: 10.7759/cureus.3386.

Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Clin Trials. 2018 Oct;15(5):499-508. doi: 10.1177/1740774518792259. Epub 2018 Aug 3.

The Impact of the Underlying Risk in Control Group and Effect Measures in Non-Inferiority Trials With Time-to-Event Data: A Simulation Study.

J Clin Med Res. 2018 May;10(5):376-383. doi: 10.14740/jocmr3349e. Epub 2018 Mar 16.

Defining the noninferiority margin and analysing noninferiority: An overview.

Br J Clin Pharmacol. 2017 Aug;83(8):1636-1642. doi: 10.1111/bcp.13280. Epub 2017 Apr 6.

本文引用的文献

Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerations.

N Engl J Med. 2011 Oct 27;365(17):1557-9. doi: 10.1056/NEJMp1110639. Epub 2011 Oct 5.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

N Engl J Med. 2010 Dec 23;363(26):2487-98. doi: 10.1056/NEJMoa1006885.

Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

PLoS One. 2010 Oct 27;5(10):e13550. doi: 10.1371/journal.pone.0013550.

Interpretation and inference in noninferiority randomized controlled trials in drug research.

Clin Pharmacol Ther. 2010 Sep;88(3):420-3. doi: 10.1038/clpt.2010.134. Epub 2010 Jul 28.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

Lancet. 2010 Mar 6;375(9717):807-15. doi: 10.1016/S0140-6736(09)62125-5.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

N Engl J Med. 2009 Aug 6;361(6):594-604. doi: 10.1056/NEJMoa0810773.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

Lancet. 2009 May 16;373(9676):1673-80. doi: 10.1016/S0140-6736(09)60734-0. Epub 2009 May 4.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

N Engl J Med. 2008 Jun 26;358(26):2776-86. doi: 10.1056/NEJMoa076016.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

J Arthroplasty. 2009 Jan;24(1):1-9. doi: 10.1016/j.arth.2008.01.132. Epub 2008 Apr 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译